Brian Powl
Corporate Officer/Principal presso KURA ONCOLOGY, INC.
Patrimonio netto: 444 235 $ in data 30/04/2024
Posizioni attive di Brian Powl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 14/08/2023 | - |
Storia della carriera di Brian Powl
Precedenti posizioni note di Brian Powl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/06/2022 | - |
| MEI PHARMA, INC. | Vendite & Marketing | 15/09/2020 | - |
Formazione di Brian Powl
| University of California San Diego | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Brian Powl
- Esperienza
